Comparison of sodium excreting effect between furosemide and indapamide combination with furosemide and metolazone combination in congestive heart failure patients - Trial SLCTR_2017_041
Access comprehensive clinical trial information for SLCTR_2017_041 through Pure Global AI's free database. This Not Applicable trial is sponsored by Rehman Medical Institute and is currently Completed. The study focuses on Congestive Heart Failure.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2017_041
Not Applicable
Completed
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2017_041
Comparison of sodium excreting effect between furosemide and indapamide combination with furosemide and metolazone combination in congestive heart failure patients
A randomized controlled trial to compare the efficacy of furosemide and indapamide combination against furosemide and metalozone combination in the sodium excreting effect in congestive heart failure
Study Focus
Interventional
Sponsor & Location
Rehman Medical Institute
Pakistan
Timeline & Enrollment
Not Applicable
Jan 01, 2018
N/A
ICD-10 Classifications
Congestive heart failure
Heart failure
Hypertensive heart disease with (congestive) heart failure
Hypertensive heart and renal disease with (congestive) heart failure
Heart failure, unspecified
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2017_041
Non-Device Trial